|Videos|February 24, 2017

How Does Wolbachia Block Dengue Virus Transmission?

Matthew Aliota, PhD, research scientist, University of Wisconsin, Pathobiological Sciences, explains why the mechanism behind how Wolbachia blocks Dengue virus transmission is not yet fully understood.

Matthew Aliota, PhD, research scientist, University of Wisconsin, Pathobiological Sciences, explains how the mechanism behind how Wolbachia blocks Dengue virus transmission is not yet fully understood.

Interview Transcript (slightly modified for readability)

“How does Wolbachia block Dengue virus transmission? That’s a good question. No one’s really sure; the exact mechanism isn’t fully understood. We think it’s probably a combination of innate immune priming in the mosquito, but there are also maybe some other molecular and biological phenomena going on that we don’t fully understand, like the production of microRNAs. The exact mechanism might differ depending on the virus that you’re talking about, because Wolbachia also blocks transmission of Zika virus and chikungunya virus. So, we know for example, that Wolbachia is really good at sucking up all of the cholesterol in a cell, and Chikungunya virus requires lots of cholesterol to package its viral particle, and so, it might just be simply a competition for resources.”


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
ID Week Highlights Part 1
In this first IDWeek 2026 roundup, oral olorofim matched AmBisome in invasive aspergillosis, aztreonam-avibactam held activity as MBL-producing CRE rose, pritelivir cut hospitalizations in refractory HSV, and zelicapavir shortened RSV symptoms in high-risk adults.